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The effect of transforming growth factor p (TGF-/I’) on the production of matrix macromolecules was studied in cultures 
of rabbit articular chondrocytes. A 24 h exposure to TGF-p at concentrations of 0.1, I and IO ng/ml markedly stimulated 
the synthesis of collagen and non-collagen protein. Similar increases of glycosaminoglycan production was observed in 
the same experimental conditions. The distribution of these newly synthesized macromolecules between cell layer and 
medium was not altered by treatment with TGF-8. The factor slightly enhanced the proliferation of chondrocytes in these 
experiments but its potent effect on matrix synthesis was independent of this growth stimulation. These results indicate 
that articular chondrocytes are target cells for TGF-p and suggest that this growth factor could play a role in the repair 
process of cartilage during osteoarticular diseases. 
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1. INTRODUCTION 
Osteoarticular diseases such as rheumatoid ar- 
thritis and osteoarthritis are characterized by an 
alteration of the cartilage extracellular matrix 
leading to irreversible lesions. Although degrada- 
tion of the main components of that tissue (col- 
lagen, proteoglycans) represents the predominant 
features in these pathologic situations [l], it has 
also been reported that synthesis and deposition of 
the matrix macromolecules could be affected [2,3]. 
A modification of collagen and proteoglycan 
metabolism directly implicates the articular chon- 
drocyte in the basic pathogenesis of these disorders 
since this cell is the producer of such components 
in cartilage. The precise nature of the mechanisms 
regulating chondrocyte metabolism is not fully 
understood. However, during the last few years, 
evidence has emerged indicating that a number of 
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mediators such as Interleukin-1 (11-l) released by 
immune and inflammatory cells have the ability to 
interact with the chondrocyte and thereby 
modulate its functional behaviour [4-61. Recent 
studies have also shown that transforming growth 
factor ,B (TGF-P), a 25 kDa protein derived from 
normal tissues and transformed cells (rev. in [7]), 
stimulates the production of fibronectin and col- 
lagen by cultured fibroblasts from several origins 
[8,9] and the synthesis of proteoglycan in arterial 
smooth muscle cells [lo]. TGF-/? is present in a 
high concentration in platelets [1 l] but it is also ex- 
pressed in activated macrophages [12] and lym- 
phocytes [13] which are the principal cellular 
elements of chronic inflammatory tissues. 
Therefore, it was of interest to determine whether 
TGF-/3 could interact with articular chondrocytes 
as target cells and modulate their matrix produc- 
tion. To date, there is but a single report indicating 
that TGF-/3 was able to decrease synthesis of 
glycosaminoglycans and collagen by rabbit ar- 
titular chondrocytes [14]. In that study, the cells 
were cultured in soft agar in three dimensions. 
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In contrast with these results, we report here that 
TGF-,6 is a potent stimulant of the synthesis of 
these matrix molecules in monolayer cultures of 
rabbit articular chondrocytes, suggesting that this 
factor could play a role in the cartilage metabolism 
2.6. Cellular protein assay 
The protein content of cell layers was determined on parallel 
dishes incubated in the same conditions. After two rinses with 
PBS, the cells were dissolved in 0.2 M NaOH (1 ml) and the 
amount of protein assayed according to Hartree [18]. 
during osteoarticular diseases. 
2. MATERIALS AND METHODS 
2.1. Chondrocyte culture 
Articular cartilage slices were taken from the shoulders and 
the knees of l-2 month old rabbits. Chondrocytes were obtain- 
ed by enzymatic dissociation [15] and cultured in DMEM 
(Dulbecco’s modified Eagle’s medium) supplemented with 
glutamine, penicillin-streptomycin-fungizone and 10% FCS 
(fetal calf serum). The cells were grown at 37°C in a 5% CO2 
environment and experiments were performed on primary con- 
fluent cultures. 
2.2. Source of TGF-,B 
Purified TGF-fl from human platelets (hTGF#r) was sup- 
plied by R & D Systems, Inc., Minneapolis, USA. 
2.3. Experimental conditions 
For the experiments, the cells were seeded in 9.6 cm2 Petri 
dishes. After reaching confluency, the cultures were incubated 
for 24 h in 1.5 ml DMEM containing 2% FCS, p- 
aminopropionitrile (100 /g/ml) and ascorbic acid (100 pg/ml). 
Then the medium was removed and I.5 ml of serum free- 
medium supplemented with ascorbic acid, fl- 
aminopropionitrile, 2 &i/ml [3H]proline (CEA, France, 
20-30 Ci/mmol) or 2 &i/ml [‘Hlglucosamine (CEA, France, 
11 Ci/mmol) was added to the dishes, together with various 
concentrations of TGF-fl (0.1-10 ng/ml). After 24 h 
radiolabeled collagen and proteoglycan were assayed in the 
culture medium and in the cell layer. Each experiment was per- 
formed in triplicate. 
The experiments described in this report were 
performed on primary cultures to avoid dedif- 
ferentiation of the chondrocytes. In such condi- 
tions, we have previously shown that rabbit 
articular chondrocytes still produce mainly type II 
collagen with only a small amount of type I col- 
lagen [5]. The cultures were confluent to minimize 
any effect of TGF-fi on cell proliferation which 
could have masked an action on collagen.synthesis 
per se. However, it was found that TGF-,# at the 
concentrations used (0.1, 1 and 10 ng/ml) in- 
creased the cell number over the 24 h period of ex- 
periment, as reflected by the cell protein amount 
(table 1). The increase was about 1.5% for the 
highest concentration of TGF-fl. Therefore, the 
levels of collagen and glycosaminoglycan synthesis 
were expressed as incorporated radiolabeled per pg 
of cell protein. 
3.2. Effect of TGF-P on protein and collagen 
synthesis 
To determine the effect of TGF-,6 on [3H]proline 
2.4. Assay of collagen and non-collagen protein Table I 
At the end of the experiment, the medium from each well was 
collected and the cell layers scraped with a rubber policeman 
and disintegrated by ultrasonication for 30 s. Radiolabeled col- 
lagen in medium and cell layer was estimated separately after 
digestion with highly purified bacterial collagenase (Advance 
Biofactures Corp., Lynbrook, NY, USA) [16]. The amount of 
non-collagen was estimated as the difference between total pro- 
tein and collagen respective radioactivities. 
Effect of TGF-fl on the amount of cellular protein 
2.5. Glycosaminoglycan ssay 
After incubation with [‘Hlglucosamine, the medium was 
removed, the cell layer was washed twice with phosphate- 
buffered saline (PBS) at 37”C, and the washes were added to 
the medium. The cell layer and 1 ml of the medium sample were 
digested with pronase (5 mg/ml, Sigma) for 24 h at 55°C. 
Glycosaminoglycans were isolated by cetylpyridinium chloride 
(I%, w/v) and ethanolic (5 ~01s) precipitations as previously 
described [17]. The final pellet was dissolved in 1 ml of 0.075 M 
NaCl and the radioactivity of an aliquot was assayed by liquid 
#g/well % of control 
Control 568 
TGFB (0.1 ng/ml) 595 +5 
TGF-fl (I ng/ml) 641 +13 
TGF;O (10 ng/ml) 654 + 15 
Confluent cultures of rabbit articular chondrocytes in 9.6 cm* 
dishes were preincubated for 24 h in 1.5 ml of DMEM 
containing 2% FCS, fl-aminopropionitrile (100 ag/ml) and 
ascorbic acid (100 pg/ml). Then the medium was removed and 
1.5 ml of the same medium without FCS was added, in the 
presence or absence of TGF@. After a 24 h incubation, the 
amount of total cell layer associated protein was estimated as 
described in section 2. Values are the mean of duplicates. 
Increases are indicated in brackets as per cent of controls scintillation counting. 
3. RESULTS 
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incorporation and collagen biosynthesis, three 
concentrations of TGF-fi were tested. The results 
shown in fig.1 (A and B) demonstrate that TGF-/3 
caused a dose-dependent stimulation of both col- 
lagen and non-collagen protein production. This 
stimulation was observed with as little as 
0.1 ng/ml (30-33% greater for both total syn- 
thesis) and reached about 80-100% for 10 ng/ml. 
The amounts of medium and cell layer associated 
protein were similarly increased so that no change 
could be detected in the distribution of newly syn- 
thesized collagen and non-collagen protein. These 
experiments clearly showed that the stimulative ef- 
fect of TGF-P was not selective for collagen. 
3.3. Effect of TGF-,L? on glycosaminoglycan 
production 
Treatment of rabbit articular chondrocytes with 
A NON-COLLAGEN PROTEIN 
*to1 
6 MEDIUM Ctll LAYER TOTAL 
.c 
Fig. 1. Effect of TGF-b on production of non-collagen (A) and 
collagen (B) protein. Experimental conditions were the same as 
for table 1, except that 2 &i/ml [3H]proline were added during 
the 24 h incubation period. At the end of the experiment, the 
amount of radiolabeled collagen was estimated in both medium 
and cell layer as collagenase-digestible radioactivity (cf. section 
2). Non-collagen protein content of the same pools was deduced 
from the difference between the value of total protein 
radioactivity and that of collagen. Values are the mean k SE of 
triplicate dishes. Increases are indicated as per cent of controls. 
GLVCOSAMINOGLVCANS . 200 
- - - 
~6F.p(nglml) 0 0.1 1 IO 
Fig.2. Effect of TGF-fl on production of glycosaminoglycan. 
Experimental conditions were the same as for table 1, except 
that 2 &i/ml [3H]glucosamine were added during the 24 h 
incubation period. At the end of the experiment, the amount of 
radiolabeled glycosaminoglycans was assayed in both medium 
and cell layer as described in section 2. Values are the mean f 
SE of triplicate dishes. Increases are indicated for the total 
amount of glycosaminoglycan as per cent of controls. 
TGF-fi over a 24 h period resulted in a significant 
increase of [3H]glucosamine incorporation into 
GAG (fig.2). The radioactivities of cellular and 
medium pools from cultures exposed to 0.1, 1 and 
10 ng/ml TGF-fl were, respectively, 1.5, 2.7 and 
3.6-fold greater than in controls. The amount of 
GAG present in the medium of control cultures 
was approx. 5-fold higher than that of cell layer. 
This relative proportion was not significantly af- 
fected by TGF-fi. 
4. DISCUSSION 
TGF-/3 has been reported to exhibit a wide spec- 
trum of regulatory activities that affect both nor- 
mal and neoplastic cells [19]. This factor exerts 
either growth-stimulating or growth-inhibiting ef- 
fects depending on the cell type. Recent studies 
have also shown that TGF-,0 stimulates matrix for- 
mation and inhibits matrix degradation by a dual 
effect: increased synthesis of protease inhibitors 
and reduced synthesis of proteases themselves 
(review [7]). The functional properties of this 
molecule are highly relevant to inflammation and 
tissue repair and therefore could be involved in 
osteoarticular diseases. 
The results presented here demonstrate that 
cultured chondrocytes which could control the 
metabolism of cartilage matrix are sensitive to 
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TGF-fl. They respond to this factor by an in- 
creased production of collagen and 
glycosaminoglycans. With reference to collagen 
synthesis, previous studies have reported a 
stimulating effect of TGF-fi on other cell lines, 
such as fibroblasts [8,9] and osteoblasts [20]. In 
contrast to the data presented by others on 
fibroblasts [9], suggesting a selective effect on col- 
lagen production, no difference in the extents of 
stimulation was observed between synthesis of col- 
lagen and non-collagen protein. 
Our results clearly indicate for the first time that 
TGF-fl also exerts a stimulatory effect on 
glycosaminoglycan synthesis by articular chon- 
drocytes. Interestingly, it has been recently 
reported that TGF-/3 could enhance synthesis of 
proteoglycan in human arterial smooth muscle 
cells [lo]. However, our results are not in agree- 
ment with those of Skantze et al. [14] describing an 
inhibition of TGF;O of collagen and GAG syn- 
thesis in cultured rabbit articular chondrocytes. AS 
a possible explanation for that discrepancy, it must 
be noted that the experimental procedure used by 
these authors was very different from ours. In that 
particular case, the cells were cultured in soft agar, 
i.e. anchorage independent growth conditions, the 
incubation period was seven days in the presence 
of TGF-fl followed by seven more days without 
factor (total: 14 days) and fetal calf serum (10%) 
was present in the culture medium all along. In 
contrast with transformed or dedifferentiated cells 
which grow in soft agar or suspension, chon- 
drocytes in these conditions keep their phenotype 
and still produce type II collagen [21] as they did 
in our primary monolayer cultures [5]. However, 
these agarose cultures are composed of clones of 
separated spherical chondrocytes whereas our 
monolayer cultures contain confluent polygonal 
cells. In fact, biochemical differences associated 
with cell shape modulation have been reported. 
For example, Wittelsberger et al. [22] have shown 
that RNA and protein synthesis in normal diploid 
cells was rapidly inhibited when these cells were 
placed in suspension cultures. Therefore, even if 
chondrocytes are well differentiated in agarose 
culture, expressing type II collagen and specific 
proteoglycans, both cell shape and lack of in- 
tercellular contact may have some influence on the 
response to TGF-fi that could account for the 
discrepant results. Another possible explanation 
may come from the presence of serum in the ex- 
periments of Skantze et al. [14], a critical point for 
the demonstration of the modulatory activity of a 
particular factor [23]. For example fetal calf serum 
contains several growth factors which could in- 
terfere with the response of cells to TGF-P. 
Moreover, it cannot be ruled out that TGF-,& may 
induce in the cultured chondrocytes the expression 
of other factors susceptible of modulating matrix 
production, especially over so long an incubation 
period. 
As only the GAG fraction of the proteoglycan 
released by articular chondrocytes has been 
assayed in our system, it remains to determine 
whether synthesis of the proteoglycan core protein 
is also affected by TGF-P. Work is in progress to 
characterize further the mechanism whereby TGF- 
,f3 stimulates the production of the main matrix 
components by articular chondrocytes. Never- 
theless, this preliminary report suggests that TGF- 
,6 may play a role in the repair response of cartilage 
to destruction generally observed in osteoarticular 
diseases. It is possible that this factor contributes 
to pathogenesis by inducing an excessive inflam- 
matory response at the level of synovial tissue and 
produces at the same time a repair process in ar- 
ticular cartilage. The above described growth- 
promoting effect and stimulation of collagen and 
glycosaminoglycan synthesis are all functional pro- 
perties of TGF;O which could be of some 
therapeutic benefit for repair of cartilage matrix by 
chondrocytes in diseases such as osteoarthritis. 
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